Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02487147 · ClinicalTrials.gov registry record · NA

Evaluation of Free Air Portable Air Powered Respirator

A NA study of Influenza, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT02487147 is a NA study of Influenza that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 58 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02487147, a NA study of Influenza, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

This study will compare the efficacy of the Free Air Portable Air Powered Respirator (PAPR) system versus a N95 mask in preventing nasal detection of influenza following an exposure. The investigators hypothesize the use of the Free Air PAPR system will be superior to a N95 respirator at interrupting the exposure of the study participants to aerosolized influenza virus particles.

Conditions Studied

Interventions

  • OTHER N95 Respirator
  • OTHER Free Air Portable Air Powered Respirator

Study Locations (1)

North Carolina

  • Wake Forest School Of Medicine - Winston-Salem

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2016-11-14
Est. Completion 2016-12-12
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02487147

The ClinicalTrials.gov registry entry for NCT02487147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which N95 Respirator is the first listed.

NCT02487147 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02487147 about?

NCT02487147 is a clinical study titled "Evaluation of Free Air Portable Air Powered Respirator". This study will compare the efficacy of the Free Air Portable Air Powered Respirator (PAPR) system versus a N95 mask in preventing nasal detection of influenza following an exposure. The investigators hypothesize the use of the Free Air PAPR system will be superior to a N95 respirator at interruptin...

What is the current status of trial NCT02487147?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-11-14. Estimated completion is 2016-12-12.

What conditions does trial NCT02487147 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT02487147?

The interventions under investigation include: N95 Respirator (OTHER), Free Air Portable Air Powered Respirator (OTHER).

Who is sponsoring clinical trial NCT02487147?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02487147 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.